Role of Microvascular Insulin Resistance and Cardiorespiratory Fitness Diabetes

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30-55
SponsorUniversity of Colorado, Denver

About this trial

The goal of this two-site grant proposal is to determine the role of the decreased insulin-mediated muscle perfusion found in type 2 diabetes in contributing to the development of cardiac and skeletal muscle dysfunction and subsequent functional exercise impairment. In addition, it is also our goal to determine whether exercise training attenuates insulin resistance and restores insulin-mediated perfusion to the heart and to skeletal muscle, leading to improved cardiac function and exercise performance.

Eligibility criteria

Qualifiers

Sedentary (defined as less than 1 hour per week of physical activity)

BMI: 25-40

Men and women with and without type 2 diabetes

Disqualifiers

Documented cardiovascular disease

Uncontrolled hypertension: disease systolic blood pressure (SBP) > 150, diastolic blood pressure (DBP)> 110

Obstructive pulmonary disease or asthma

Peripheral neuropathy

Trial design

Treatments tested in this trial

  • Cardiovascular exercise

Treatment groups

150 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Colorado, Denver

Lead sponsor

University of Virginia

Collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator